✦ LIBER ✦

Association of EGF receptor expression with proliferating cells and of ras p21 expression with differentiating cells in various skin tumors

✍ Scribed by Kikuchi, A.; Amagai, M.; Hayakawa, K.; Shimizu, N.; Nishikawa, T.

Book ID: 122644221
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 160 KB
Volume: 1
Category: Article
ISSN: 0923-1811
DOI: 10.1016/0923-1811(90)90157-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distribution of DNA replicating cells an

Distribution of DNA replicating cells and EGF receptor-expressing cells in overlying epidermis of various skin tumors

✍ Kikuchi, Arata; Sakuraoka, Koichi 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Association of ras p21 with differentiat

Association of ras p21 with differentiation of epidermal keratinocytes in proliferating skin diseases

✍ Kikuchi, Arata; Amagai, Masayuki; Nishikawa, Takeji 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 426 KB

EGF receptor signaling induces prolifera

EGF receptor signaling induces proliferation of intestinal epithelial cells via MAPK-directed increase in p21 expression

✍ G.S. Sheng; B.W. Warner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

P21 RNA and protein expression in non-sm

P21 RNA and protein expression in non-small cell lung carcinomas: Evidence of p53-independent expression and association with tumoral differentiation

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Expression of endothelin system in neuro

Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells

✍ Nobuo Hoshi; Takashi Sugino; Toshimitsu Suzuki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 784 KB

Pyrimido-pyrimidine modulation of EGF gr

Pyrimido-pyrimidine modulation of EGF growth-promoting activity and p21ras expression in rat mammary adenocarcinoma cells

✍ Rosemarie B. Lichtner; Gary E. Gallick; Garth L. Nicolson 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 804 KB

RA 233, a pyrimido-pyrimidine analogue developed originally as an antiplatelet agent, has reduced the incidence of tumor metastases in clinical trials. However, in animal tumor models antimetastatic therapy using RA 233 has been inconsistent. We therefore tested RA 233 for additional effects, such a